| DIRECT COMPETITOR COMPARISON | |
| MBRK | BVF | JNJ | TEVA | Industry | | Market Cap: | 46.72M | 2.21B | 179.18B | 49.57B | 169.04M | | Employees: | 352 | N/A | 118,700 | 38,307 | 103 | | Qtrly Rev Growth (yoy): | -50.80% | 17.40% | -5.30% | 24.90% | 20.50% | | Revenue (ttm): | 13.90M | 760.87M | 60.53B | 12.95B | 46.74M | | Gross Margin (ttm): | 86.74% | 71.90% | 71.08% | 55.30% | 55.30% | | EBITDA (ttm): | -49.51M | 359.76M | 19.05B | 3.94B | -7.12M | | Oper Margins (ttm): | -379.39% | 30.18% | 26.94% | 24.35% | 2.08% | | Net Income (ttm): | -58.17M | 223.84M | 12.77B | 953.00M | N/A | | EPS (ttm): | -0.672 | 1.413 | 4.579 | 1.093 | -0.17 | | P/E (ttm): | N/A | 9.88 | 14.18 | 51.48 | 17.72 | | PEG (5 yr expected): | N/A | 1.39 | 1.87 | 1.12 | 1.07 | | P/S (ttm): | 3.61 | 2.92 | 2.95 | 3.81 | 4.48 |
|
| BVF = Biovail Corporation | | JNJ = Johnson & Johnson | | TEVA = Teva Pharmaceutical Industries Limited | | Industry = Drug Manufacturers - Other | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.66 | 0.42% | 58.36B | 12.58 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 53.27 | 1.97% | 15.41B | 17.83 | | Genzyme Corp. | GENZ | 49.61 | 2.29% | 13.17B | 28.28 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.26 | 0.60% | 38.93B | 16.73 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 52.70 | 1.02% | 9.40B | 1075.51 | | Teva Pharmaceutical Industries Limited | TEVA | 56.27 | 0.59% | 49.57B | 51.48 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 40.12 | 0.53% | 4.26B | 20.68 | | King Pharmaceuticals Inc. | KG | 12.21 | 0.58% | 3.03B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.69 | -0.27% | 5.71B | 114.66 | | Pfizer Inc. | PFE | 18.63 | 0.16% | 150.34B | 15.47 | | Johnson & Johnson | JNJ | 64.94 | 0.37% | 179.18B | 14.18 | | GlaxoSmithKline plc | GSK | 42.47 | 0.43% | 107.66B | 13.92 | | Sanofi-Aventis | SNY | 40.38 | 1.28% | 105.44B | N/A | | Novartis AG | NVS | 54.75 | -0.16% | 124.35B | 16.39 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 42.88 | -0.74% | N/A | N/A | | AstraZeneca plc | AZN | 46.76 | 0.82% | 67.80B | 9.39 | | Abbott Laboratories | ABT | 54.53 | 0.70% | 84.34B | 14.77 | | Bristol-Myers Squibb Co. | BMY | 25.95 | 0.74% | 51.41B | 13.42 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | JNJ | | Health-Care Stocks Stuck in Waiting Room
Mon 3:45pm -
at Barrons.com | | • | JNJ | | 6 All-Star Stocks to Make Your Portfolio Shine
Mon 2:41pm -
at Motley Fool | | • | JNJ | | ETFs for an Uncertain Future
Mon 1:46pm -
at Motley Fool | | • | JNJ | | Roundtable: Investing in a No-Growth Market
Mon 11:35am -
at Motley Fool | | • | TEVA | | Teva Expands Cancer Portfolio
Mon 11:12am -
Zacks.com | | • | TEVA | | Compugen Soars 32% on Cancer Target Find
Mon 11:06am -
at Barrons.com | | • | TEVA | | FDA Delays Nuvigil Decision
Mon 11:04am -
Zacks.com | | • | JNJ | | BSX Settles DOJ Investigation
Mon 9:53am -
Zacks.com | | • | JNJ | | [$$] Sanofi's Trendy Move to Consumer Products
Sun 2:53pm -
at The Wall Street Journal Online | | • | TEVA | | Teva joint venture buys stake in Japan drugmaker
Thu, Dec 24 -
AP | | • | TEVA | | Israel Stocks: Israel stocks up; Teva gets lift; Givot finds oil
Thu, Dec 24 -
at MarketWatch | | • | TEVA | | Teva Deal a Reality Check for OncoGenex Investors
Thu, Dec 24 -
at Seeking Alpha | | • | TEVA | | Five Fast-Growing Stocks to Own
Thu, Dec 24 -
at TheStreet.com | | • | TEVA | | Teva-Kowa to buy 2/3 of closely held Taisho
Thu, Dec 24 -
at MarketWatch | | • | TEVA | | Teva-KOWA Pharma to Acquire a Majority Share Interest in Taisho Pharmaceutical Industries
Thu, Dec 24 -
Business Wire | | • | BVF | | Coverage initiated on Biovail by Thomas Weisel
Thu, Dec 17 -
Briefing.com | | • | BVF | | One Investment to Avoid in Today's Market
Sat, Dec 12 -
at Motley Fool | | • | BVF | | SPECIAL REPORT-The FBI agent inside the Galleon case
Fri, Dec 4 -
at Reuters | | • | BVF | | The FBI agent inside the Galleon case
Fri, Dec 4 -
Reuters | | • | BVF | | Abbott Makes All the Right Moves
Tue, Dec 1 -
at Motley Fool | | | All Headlines for these symbols... |
|
|
|
0.26% Nasdaq 
0.04 (6.90%) 
Competitors
